NCT06459388 Stabilizing Reversal and Rhythmic Stabilization vs Pelvic Proprioceptive Neuromuscular Facilitation in Stroke Patients
| NCT ID | NCT06459388 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Stroke, Ischemic |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-05-01 |
| Primary Completion | 2025-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2024-05-01 with a primary completion date of 2025-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to compare the effects of stabilizing reversal and rhythmic stabilization versus pelvic proprioceptive neuromuscular facilitation on trunk control, postural stability and mobility in stroke patients. The main question it aims to answer is: Is there any difference in effects of stabilizing reversal and rhythmic stabilization versus pelvic proprioceptive neuromuscular facilitation on trunk control, postural stability and mobility in stroke patients? Researchers will compare stabilizing reversal and rhythmic stabilization to pelvic proprioceptive neuromuscular facilitation to see if there any difference in effects of stabilizing reversal and rhythmic stabilization versus pelvic proprioceptive neuromuscular facilitation on trunk control, postural stability and mobility in stroke patient. Participants will be divided into two groups: Group A will receive stabilizing reversals and rhythmic reversals technique. The patient will perform 3 sets with 15 repetitions in each session, 5 days per week for 8 weeks. Group B will receive Pelvic PNF protocol. The treatment protocol will be followed 5 days a week for 8 weeks (i.e. 20 sessions) and each session will last for 30 minutes.
Eligibility Criteria
Inclusion Criteria: * Diagnosed cases of ischemic stroke. * Both genders of stroke patients. * Age of stroke patients between 40-65 years. * Duration of stroke less than 6 months. * Participants should be able to understand and follow simple verbal commands (MMSE * 24). Exclusion Criteria: * Recurrent history of stroke. * Recent history of any trauma. * Musculoskeletal disorders such as low back pain, arthritis, degenerative diseases of the lower limbs affecting motor performance, spinal deformity and contractures. * Spasticity (modified Ashworth scale grade ≥3) or flaccidity in lower limbs and upper limbs. * PNF treatment given to the pelvic region within 6 weeks.
Contact & Investigator
Wajiha Shahid, Phd*
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT06459388 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 65 Years, studying Stroke, Ischemic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06459388 currently recruiting?
Yes, NCT06459388 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT06459388 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT06459388 clinical trial?
NCT06459388 is sponsored by Riphah International University. The principal investigator is Wajiha Shahid, Phd* at Riphah International University. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.